Titlebook: Rare Rheumatic Diseases of Immunologic Dysregulation; Teresa Kathleen Tarrant Book 2019 Springer Nature Switzerland AG 2019 Rheumatology.I

滲透

IgG4-Related Disease,oid responsiveness. IgG4-RD responds well to steroids, but it sometimes relapses. Rituximab has recently been reported to be useful for its treatment. Although the short-term outcome is usually good, the long-term prognosis is unknown.

A精確的

FRAX-tool

Remitting Seronegative Symmetrical Synovitis and Pitting Edema,racteristics of RS3PE, associated conditions including malignancy, diagnosis and management, as well as current data on mechanism of disease pathogenesis including areas of ongoing research and future directions.

評(píng)論性

2524-7794 umatic Diseases of Immunologic Dysregulation. is an invaluable resource for rheumatologists, rheumatology fellows, and clinical immunologists to better diagnose and treat patients with rare rheumatic diseases..978-3-319-99138-2978-3-319-99139-9Series ISSN 2524-7794 Series E-ISSN 2524-7808

工作

978-3-319-99138-2Springer Nature Switzerland AG 2019

ODIUM

Rare Rheumatic Diseases of Immunologic Dysregulation978-3-319-99139-9Series ISSN 2524-7794 Series E-ISSN 2524-7808

Medicaid

maladorit

ear-canal

https://doi.org/10.1007/978-3-319-99139-9Rheumatology; Immunologic Dysregulation; Rare Diseases; Diagnosis; Treatment; Immunology

BORE